CClinicalTrials.gg
CompletedNCT03664934Updated Oct 3, 2023

Pathophysiological Mechanism Behind Prolonged Whiplash Associated Disorders

An interventional study of Exercises in Whiplash Injuries, sponsored by Linkoeping University. Completed at 1 site in Sweden. Open to participants aged 18 Years to 63 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-10-03.

Sponsored by Linkoeping University · Not applicable, Interventional, and Diagnostic

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Non-randomized
Ages
18 Years to 63 Years
Sex
All
01

Study summary

The knowledge of pathophysiological mechanisms behind prolonged Whiplash Associated Disorders (WAD) is insufficient and whether changes can be restored by rehabilitation or not is unknown. The aim of these studies are to investigate different parameters to further learn about pathophysiological mechanisms (neck muscle fatty infiltration, cross-sectional area, volume, inflammation and function, brain structure and activity, biomarkers for stress and inflammation, cervical kinaesthesia and balance before and after intervention) and the association for clinical outcomes in individuals with chronic WAD (n=30) compared with age and gender matched healthy individuals (n=30). Measurements will be made at baseline (patients and healthy) and at 3 months (patients only, at the end of treatment). However, for the blood and saliva samples, they will be re-investigated in the healthy group as well. The study results may contribute to the development of improved understanding and diagnostics in chronic WAD that may improve future rehabilitation.

Read the detailed description

BACKGROUND There is no consensus regarding the injury mechanism in complex prolonged Whiplash Associated Disorders (WAD) cases. Often, tissue damage and physiological alterations is not detectable. In order to improve future rehabilitation, a greater understanding of the mechanisms underlying whiplash injury and their importance for treatment success is required. It is also important to investigate if pathophysiological changes can be restored by rehabilitation.

AIM The projects aims to investigate neck muscle structure and function, biomarkers and the association with pain, disability and other outcomes before and after neck-specific exercises.

METHODS Design These are sub-group trials, each one independent of the others, in a prospective, multicentre, randomized controlled trial (RCT) with two parallel treatment arms conducted according to a protocol established before recruitment started (ClinicalTrials.gov Protocol ID: NCT03022812). Physiotherapist-led neck-specific exercise previously shown to be effective for the current population constitutes the control treatment for the new Internet-based neck-specific exercise treatment. In the RCT, a total of 140 patients will be included (70 from each group), whereof 30 (both randomization arms equally) consecutively will be asked to participate in the present sub-group study. The sub-group studies aims to start September 2019. Independent physiotherapists in primary health care will distribute the treatment.

In sub-group of individuals, additional measurements will be performed before and after interventions end (3 months follow-up). The physical measurements will be performed by independent specially trained test-leaders blinded to randomization.

Additionally, 30 neck healthy individuals without serious diseases matched for age and gender will consecutively be investigated.

Study population

The inclusion criteria for patients are:

  • Chronic neck problems corresponding to WAD grades 2-3 verified by clinical examination
  • Average estimated pain in the last week at least 20 mm on the visual analogue scale (VAS)
  • Neck disability of more than 20% on the Neck Disability Index (NDI) [10]
  • Working age (18 - 63 years)
  • Daily access to a computer/tablet/smart phone and Internet
  • Neck symptoms within the first week after the injury (i.e., neck pain, neck stiffness, or cervical radiculopathy).

For the present sub group study additional criteria were:

  • Right handed
  • Dominant right sided or equal sided pain

Inclusion criteria for healthy controls:

  • Age and gender matched healthy individuals without neck pain and disability (VAS \<10mm, NDI \<5%) that feel overall healthy without known diseases.

Exclusion criteria for patients:

  • Individuals with any of the following signs of head injury at the time of whiplash injury will be excluded: loss of consciousness, amnesia before or after the injury, altered mental status (e.g., confusion, disorientation), focal neurological changes (changes in smell and taste).
  • Previous fractures or dislocation of the cervical spine
  • Known or suspected serious physical pathology included myelopathy,
  • Spinal tumours
  • Spinal infection
  • Ongoing malignancy
  • Previous severe neck problems that resulted in sick leave for more than a month in the year before the current whiplash injury
  • surgery in the cervical spine
  • Generalized or more dominant pain elsewhere in the body
  • Other illness/injury that may prevent full participation
  • Inability to understand and write in Swedish

Additional criteria in the present sub group:

  • Increased risk of bleeding,
  • BMI >35
  • Contraindications of MRI such as metal, severe obesity, pacemaker and pregnancy.

Exclusion criteria for healthy controls:

  • Earlier neck injury,
  • Recurrent neck pain,
  • Earlier treatment for neck pain.
  • Increased risk of bleeding,
  • BMI >35
  • Contraindications of MRI

Recruitment and randomization Information about the study will be provided by healthcare providers, reports in newspapers, social media, and the university's website. Interested patients will contact the research team through the project website. After completing a small survey on the website, a project team member (physiotherapist) will perform a telephone interview and ask about the patient's medical history. An appointment for a physical examination and additional interview for the present sub-group study is made as a last step to ensure that the criteria for study participation are met. If the study criteria are met, written and oral informed consent are obtained, and the patient will fill out a questionnaire and undergo physical measurements of neck-related function. Baseline measurements must be completed for inclusion.

Healthy individuals will consecutively be recruited among friends, family and staff at the university or the university hospital to suit the age and gender of a patient.

Intervention for the patient group The intervention consists of neck-specific exercises distributed in two different ways, twice a week at the physiotherapist clinic for 3 months (NSE group) or with 4 physiotherapy visits only combined with a web-based system (NSEIT group).

A. In the NSE group, patients will get an explanation and justification for the exercise consisting of basic information about the musculoskeletal anatomy of the neck relevant to the exercises given by the physiotherapist in order to motivate the patient and help make them feel safe and reassured. The patients undergo a 12-week training programme with a physiotherapist 2 days/week (total 24 times). Exercises are chosen from a clear and written frame of exercises. The training includes exercises for the deep neck muscles, continuing with the endurance training of neck and shoulder muscles. The exercises are individually adjusted according to the individual's physical conditions and progressively increased in severity and dose. Exercise-related pain provocation is not accepted. The patient may also perform exercises at home. At the end of the treatment period, the participants are encouraged to continue practising on their own. The exercises have been used with good results in previous RCTs.

B. In the NSEIT group, patients will receive the same information and training programmes as the NSE group, but with 4 visits to the physiotherapist instead of 24. Exercises are introduced, progressed, and followed up to ensure correct performance. The exercises are performed and most of the information is given with the help of Internet support outside the healthcare system. Photos and videos of the exercises (a clear stepwise progression) and information are available on the Web-based system. A SMS reminder is automatically available if the exercise diary is not completed. The time required for training is the same as in group A, but without the patient having to go to the physiotherapy clinic. The Internet programme was developed by experienced physiotherapists/ researchers together with technicians and clinicians. Technicians are available to assist the participants if any technical difficulties arise. The patients will be introduced to the exercises and get information and support at the physiotherapy visits.

Variables and measurements Background data and data in the RCT include personal details, questionnaires and test results regarding pain, physical and psychological functioning, health and cost-effectiveness described elsewhere (ClinicalTrials.gov Protocol ID: NCT03022812).

Measurements will be done at baseline for both groups and at 3 months follow-up for the patient when treatment ends. Except for blood and saliva samples that will be collected twice (baseline and repeated after 3 months), the measurements will be performed at baseline only for the healthy individuals.

02

Conditions studied

  • Whiplash Injuries

Browse trials for

Keywords

  • Neck pain, Rehabilitation, Muscles, Clinical Trial,
  • Diagnostics
03

In context

Whiplash Injuries

68 studies on the registry are indexed under Whiplash Injuries; 8 are open to participants now.

This study's enrollment of 60 is below the median of 68 across 49 interventional studies indexed under Whiplash Injuries.

Browse Whiplash Injuries studies →

Lead sponsor

Linkoeping University is the lead sponsor of 189 studies on the registry; 40 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 63 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

Study population

The inclusion criteria for patients are:

  • Chronic neck problems corresponding to WAD grades 2-3 verified by clinical examination
  • Average estimated pain in the last week at least 20 mm on the visual analogue scale (VAS)
  • Neck disability of more than 20% on the Neck Disability Index (NDI) [10]
  • Working age (18 - 63 years)
  • Daily access to a computer/tablet/smart phone and Internet
  • Neck symptoms within the first week after the injury (i.e., neck pain, neck stiffness, or cervical radiculopathy).

For the present sub group study additional criteria were:

  • Right handed
  • Dominant right sided or equal sided pain

Inclusion criteria for healthy controls:

  • Age and gender matched healthy individuals without neck pain and disability (VAS \<10mm, NDI \<5%) that feel overall healthy without known diseases.

Exclusion criteria for patients:

  • Individuals with any of the following signs of head injury at the time of whiplash injury will be excluded: loss of consciousness, amnesia before or after the injury, altered mental status (e.g., confusion, disorientation), focal neurological changes (changes in smell and taste).
  • Previous fractures or dislocation of the cervical spine
  • Known or suspected serious physical pathology included myelopathy,
  • Spinal tumours
  • Spinal infection
  • Ongoing malignancy
  • Previous severe neck problems that resulted in sick leave for more than a month in the year before the current whiplash injury
  • surgery in the cervical spine
  • Generalized or more dominant pain elsewhere in the body
  • Other illness/injury that may prevent full participation
  • Inability to understand and write in Swedish

Additional criteria in the present sub group:

  • Increased risk of bleeding,
  • BMI >35
  • Contraindications of MRI such as metal, severe obesity, pacemaker and pregnancy.

Exclusion criteria for healthy controls:

  • Earlier neck injury,
  • Recurrent neck pain,
  • Earlier treatment for neck pain.
  • Increased risk of bleeding,
  • BMI >35
  • Contraindications of MRI such as metal, severe obesity, pacemaker and pregnancy.
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
60 participants (actual)

Study arms

  • Experimental
    Patients, Neck-specific exercises

    Patients before and after neck-specific exercises, subgroup to NCT01528579 with additional measures

    Other: Exercises

  • No intervention
    Healthy controls

    Healthy controls, no treatment

Interventions

  • OtherExercises

    Neck-specific exercises for chronic whiplash associated disorders

    Also known as: No treatment, controls only

06

What researchers measure

Primary outcomes

  1. Speckle tracking analyses of neck and shoulder muscle function

    Measured with medical ultrasonography during neck and arm exercises

    Time frame: Baseline and at 3 months follow-up when intervention ended. The outcome measure is going to report a change over time for patients.

  2. Cross-sectional area, volume, fatty infiltration and inflammation of neck muscles

    Neck and some whole body imaging measured with 3.0 T MRI scanner

    Time frame: Baseline, 3 months. The outcome measure is going to report a change over time for patients.

  3. Brain function in cortical networks related to pain

    Measured with a resting-state fMRI protocol with an echo planar imaging (EPI) sequence

    Time frame: Baseline, 3 months. The outcome measure is going to report a change over time for patients.

  4. Biomarkers for inflammation and stress

    Measured with blood samples and saliva

    Time frame: Baseline, 3 months. The outcome measure is going to report a change over time for patients.

  5. Cervikal kinaesthesia

    Neck-eye coordination

    Time frame: Baseline, 3 months. The outcome measure is going to report a change over time for patients.

  6. Balance test

    Postural sway during single and double leg stance

    Time frame: Baseline, 3 months. The outcome measure is going to report a change over time for patients.

Secondary outcomes

  1. Neck Disability Index (NDI)

    Self-reported neck-specific function. Score 0 to 50 (or in percentages 0% to 100%); 0p/0%=no disability, 50p/100%=complete activity limitation

    Time frame: Change from baseline to 3 months (the end of treatment) and 15 months (1 year after study treatment is finalized) follow-up

  2. Whiplash Disability Questionnaire

    Disability associated with whiplash, in patients. Score 0 to 130; 0=no disability, 130=maximum disability.

    Time frame: Change from baseline to 3 months (the end of treatment) and 15 months (1 year after study treatment is finalized) follow-up

  3. Patient-specific functional scale (PSFS)

    Individual ratings of function to quantify activity limitations, in patients. Score 0-10 score; 0= Unable to perform activity, 10= Able to perform activity at the same level as before injury or problem. Total score=sum of the activity scores/ number of activities.

    Time frame: Change from baseline to 3 months (the end of treatment) and 15 months (1 year after study treatment is finalized) follow-up

  4. Pain intensity in neck, head, and arm and dizziness by a Visual Analogue Scale (VAS) (0-100 mm; where 0=no pain, 100= worst imaginable pain )

    Pain intensity. Score 0 to 100 mm; 0=no pain, 100=worst imaginable pain

    Time frame: Change from baseline to 3 months (the end of treatment) and 15 months (1 year after study treatment is finalized) follow-up

  5. Distribution of pain by a pain drawing assessed with images

    Distribution of pain, in patients

    Time frame: Change from baseline to 3 months (the end of treatment) and 15 months (1 year after study treatment is finalized) follow-up

  6. Frequency of pain

    Frequency of pain, in patients

    Time frame: Change from baseline to 3 months (the end of treatment) and 15 months (1 year after study treatment is finalized) follow-up

  7. Use of pain medications

    Use of pain medications, in patients

    Time frame: Change from baseline to 3 months (the end of treatment) and 15 months (1 year after study treatment is finalized) follow-up

  8. Dizziness/balance by the Dizziness Handicap Inventory (DHI)

    Dizziness questionnaire, in patients

    Time frame: Change from baseline to 3 months (the end of treatment) and 15 months (1 year after study treatment is finalized) follow-up

  9. Headache Questions by VAS and the Headache Impact Test (HIT-6)

    Impact of headache, in patients

    Time frame: Change from baseline to 3 months (the end of treatment) and 15 months (1 year after study treatment is finalized) follow-up

  10. Pain Catastrophizing Scale (PCS), total scores range from 0 - 52; 0=no catastrophizing, 52= maximum catastrophizing

    Self-reported pain catastrophizing, in patients

    Time frame: Change from baseline to 3 months (the end of treatment) and 15 months (1 year after study treatment is finalized) follow-up

  11. EuroQuol five dimensions

    Self-reported health, in patients

    Time frame: Change from baseline to 3 months (the end of treatment) and 15 months (1 year after study treatment is finalized) follow-up

  12. Effort Reward Imbalance questionnaire

    Work related balance between effort and reward, in patients

    Time frame: Change from baseline to 3 months (the end of treatment) and 15 months (1 year after study treatment is finalized) follow-up

  13. Symptoms Satisfaction scale

    Satisfaction with present symptoms, in patients. 1 to 7 scale; 1=delighted, 7=terrible.

    Time frame: Change from baseline to 3 months (the end of treatment) and 15 months (1 year after study treatment is finalized) follow-up

  14. Physical activity score, a combination score of the 2 questions (everyday physical activity and exercise/sport/open-air activity) to a combined 4-point score

    Physical activity. Score 0 to 4; 0=inactivity, 4=high activity.

    Time frame: Change from baseline to 3 months (the end of treatment) and 15 months (1 year after study treatment is finalized) follow-up

  15. Health care consumption, number of visits

    Health care consumption, in patients

    Time frame: Change from baseline to 3 months (the end of treatment) and 15 months (1 year after study treatment is finalized) follow-up

  16. Self-Efficacy Scale (SES)

    Self-reported self-efficacy, in patients. Score 0-200; 0=no self-efficacy, 200=strong self-efficacy

    Time frame: Change from baseline to 3 months (the end of treatment) and 15 months (1 year after study treatment is finalized) follow-up

  17. Fear Avoidance Beliefs Questionnaire (FABQ)

    Fear Avoidance Beliefs, in patients

    Time frame: Change from baseline to 3 months (the end of treatment) and 15 months (1 year after study treatment is finalized) follow-up

  18. Hospital Anxiety and Depression Scale (HAD)

    Depression and anxiety. Each subscale (depression and anxiety) range from 0 to 21; 0=normal, 21=severe

    Time frame: Change from baseline to 3 months (the end of treatment) and 15 months (1 year after study treatment is finalized) follow-up

  19. Post Traumatic Stress Disorder checklist (PCL-S)

    Post Traumatic Stress, in patients

    Time frame: Change from baseline to 3 months (the end of treatment) and 15 months (1 year after study treatment is finalized) follow-up

  20. Range of neck motion

    Range of motion, in patients

    Time frame: Change from baseline to 3 months (the end of treatment) and 15 months (1 year after study treatment is finalized) follow-up

  21. Ergonomics questions and how work is perceived

    Work ergonomics, in patients

    Time frame: Change from baseline to 3 months (the end of treatment) and 15 months (1 year after study treatment is finalized) follow-up

  22. Sickness presence by the Stanford presenteeism scale (SPS-6)

    Sickness presence at work, impact of health problems on individual work performance and overall perceived productivity , in patients. Scores 6-30, with lower scores indicting lower Presenteeism, and higher scores indicating higher Presenteeism.

    Time frame: Change from baseline to 3 months (the end of treatment) and 15 months (1 year after study treatment is finalized) follow-up

  23. Patient Enablement Instrument (PEI) questionnaire

    Patient enablement, in patients

    Time frame: Change from baseline to 3 months (the end of treatment) and 15 months (1 year after study treatment is finalized) follow-up

  24. Consumption of analgesic drugs prescribed through the drug registry

    Consumption of analgesic drugs, in patients

    Time frame: Change from baseline to 3 months (the end of treatment) and 15 months (1 year after study treatment is finalized) follow-up

  25. Sick-leave registration, number of days and episodes

    Sick-leave, in patients

    Time frame: Change from baseline to 3 months (the end of treatment) and 15 months (1 year after study treatment is finalized) follow-up

  26. Cognitive failures questionnaire (CFQ)

    Cognitive function, in patients

    Time frame: Change from baseline to 3 months (the end of treatment) and 15 months (1 year after study treatment is finalized) follow-up

  27. Sensorimotor control of the neck muscles, mm Hg

    Sensorimotor control, in patients

    Time frame: Change from baseline to 3 months (the end of treatment) and 15 months (1 year after study treatment is finalized) follow-up

  28. Neck muscle endurance of ventral and dorsal neck muscles in seconds

    Neck muscle endurance, in patients

    Time frame: Change from baseline to 3 months (the end of treatment) and 15 months (1 year after study treatment is finalized) follow-up

  29. Balance measured in seconds, standing on one leg with eyes closed

    Balance, in patients

    Time frame: Change from baseline to 3 months (the end of treatment) and 15 months (1 year after study treatment is finalized) follow-up

  30. Neurology

    Clinical examination of neurology, in patients, such as reflexes, sensibility, muscle weakness, Spurling´s test, neural tension test.

    Time frame: Change from baseline to 3 months (the end of treatment) and 15 months (1 year after study treatment is finalized) follow-up

  31. Work Ability Index (WAI)

    Self-reported work ability, in patients

    Time frame: Change from baseline to 3 months (the end of treatment) and 15 months (1 year after study treatment is finalized) follow-up

  32. Global rating of change scale

    Overall change because of the treatment, in patients. Score -5 (very much worse to +5 completely recovered and importance of change 0=not at all important, 100= very important.

    Time frame: Change from baseline to 3 months (the end of treatment) and 15 months (1 year after study treatment is finalized) follow-up

Other outcomes

  1. Background data such as age and gender, living circumstances

    Background data such as age, gender, living circumstances

    Time frame: Baseline

07

Study locations

1 site
  • Linköping University
    Linköping, Östergötland 58183, Sweden
08

References and documents

Publications

  • Peolsson A, Karlsson A, Ghafouri B, Ebbers T, Engstrom M, Jonsson M, Wahlen K, Romu T, Borga M, Kristjansson E, Bahat HS, German D, Zsigmond P, Peterson G. Pathophysiology behind prolonged whiplash associated disorders: study protocol for an experimental study. BMC Musculoskelet Disord. 2019 Feb 2;20(1):51. doi: 10.1186/s12891-019-2433-3. PubMed 30711003 ↗

Study documents

  • Study protocol · Aug 31, 2018
  • Statistical analysis plan · Aug 31, 2018
  • Informed consent form · Sep 6, 2018

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: Undecided — Unidentified data may be available upon resonable request (may need approval from the ethics comittee as it contains data about health).

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 3, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03664934
Lead sponsor
Linkoeping University
Responsible party
Anneli Peolsson (Professor, PhD, PT, Linkoeping University) — Principal investigator
First posted
Sep 11, 2018
Start date
Oct 4, 2018
Primary completion
Dec 16, 2021
Completion
Dec 16, 2021
Last update
Oct 3, 2023

Study contacts

Anneli Peolsson, Professor
principal investigator · Linkoeping University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion